Back to search
Beta Lactam Allergy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Beta Lactam Allergy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Beta Lactam Allergy trials you may qualify forThe purpose of this study is to demonstrate the feasibility of direct oral challenge performed in private practice setting for children with suspected benign de…
The overall goal of the RENEW-IN intervention is to assess the impact of a BL allergy delabeling intervention on antibiotic use and clinical outcomes in patient…
Cephalosporin antibiotics are commonly used but can result in allergic reactions and anaphylaxis. There is no clear diagnostic approach for cephalosporin-allerg…
Antibiotic allergy labels (AAL) are reported in 7% of inpatient's charts, especially for beta-lactams (86% of AAL, i.e., prevalence of 6%). They are associated…
Beta-lactams are the most common antibiotics prescribed to children, including penicillin and amoxicillin. They are usually more effective and have fewer side e…
The goal of this RENEW-EVAL project is to understand the potential barriers to implementation of the RENEW intervention into the routine clinical care of patien…
Drug provocation tests (DPT) are widely in case of suspicion of drug hypersensitivity (and in the absence of contraindications), but there are no standardized p…